HPC-based Covid-19 Single-Cell RNA Sequencing

Understanding how the novel corona virus (called SARS‐CoV‐2) responsible for the COVID-19 pandemic works is an important step in developing successful treatment. Charité and the Berlin Institute of Health (BIH) are using Intel’s high performance computing (HPC) architecture to successfully perform compute-intensive RNA sequencing on the single-cell level in a highly efficient manner. Intel is well positioned to assist in this effort through its deep IT knowledge, ecosystem scale, and experience in the health and life sciences industry.

Please fill your information below to download the case study.

* Email

* First Name

* Last Name

* Company

* Job Title

* Country

* Phone Number

By submitting this form, you are confirming you are an adult 18 years or older and you agree to share your personal information with Intel to use for this business request. You also agree to Intel and Madison Logic contacting you with marketing-related emails or by telephone. You may unsubscribe from Intel and Madison Logic at any time.

Yes, I subscribe to receive marketing communications from APSS media and its partner about products, events and services. For information on how APSS media uses and protects your personal data, see our Privacy Statement. You can unsubscribe at any time.